PacBio Grants Equity Incentive Award to New Employee
January 14, 2022 16:05 ET
|
PacBio
MENLO PARK, Calif., Jan. 14, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
PacBio Names Lara Toerien as Vice President and General Manager for the Americas
January 13, 2022 07:00 ET
|
PacBio
MENLO PARK, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, welcomes Lara Toerien, Ph.D., as Vice...
PacBio and Berry Genomics Announce Collaboration to Bring Long Read Desktop Sequencing Instrument to the Clinical Market in China
January 11, 2022 07:15 ET
|
Pacific Biosciences of California, Inc.
New collaboration builds on existing relationship between the two companies to develop desktop systems for the clinical market in China Berry Genomics to purchase at least 50 instruments at product...
PacBio Announces Collaboration with Genomics England to Sequence Biobanked Rare Disease Samples Using HiFi Sequencing Technology
January 11, 2022 07:10 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration with Genomics...
PacBio and Google Collaborate to Use Machine Learning to Optimize Long-Read Sequencing Data Analysis
January 11, 2022 07:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced a research collaboration with...
PacBio Announces Record Preliminary Fourth Quarter 2021 Revenue, New Sequencing Kits and Workflows, and Expanded Collaborations
January 11, 2022 07:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced unaudited preliminary revenue...
Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe
January 07, 2022 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical...
Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems
January 06, 2022 09:00 ET
|
Pacific Biosciences of California, Inc.; Azenta Life Sciences
MENLO PARK, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The...
PacBio and Care4Rare Consortium Collaborate on Rare Disease Research Study
January 05, 2022 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they...
PacBio to Present at Upcoming Investor Conference
January 04, 2022 16:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that its executives will be speaking virtually at the following investor conference: 40th Annual J.P. Morgan Healthcare...